Bullish
Scienture (SCNX) Secures Patent for Rezenopy Nasal Spray
Scienture Holdings Inc. (SCNX) has been awarded U.S. Patent No. 12,622,903 B2 for its Rezenopy Nasal Spray, effective until 2041, which solidifies its...
Bullish
Scienture Holdings Inc. (SCNX) has been awarded U.S. Patent No. 12,622,903 B2 for its Rezenopy Nasal Spray, effective until 2041, which solidifies its...